"Flucytosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fluorinated cytosine analog that is used as an antifungal agent.
| Descriptor ID |
D005437
|
| MeSH Number(s) |
D03.383.742.698.421.431
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Flucytosine".
Below are MeSH descriptors whose meaning is more specific than "Flucytosine".
This graph shows the total number of publications written about "Flucytosine" by people in this website by year, and whether "Flucytosine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 2 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flucytosine" by people in Profiles.
-
Disseminated Cryptococcus neoformans infection in a left ventricular assist device recipient. BMJ Case Rep. 2019 Apr 08; 12(4).
-
Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells. Neurosurgery. 2016 Sep; 79(3):481-91.
-
Neuro-ophthalmic presentations and treatment of Cryptococcal meningitis-related increased intracranial pressure. Can J Ophthalmol. 2014 Oct; 49(5):473-7.
-
Invasive mycoses: strategies for effective management. Am J Med. 2012 Jan; 125(1 Suppl):S25-38.
-
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase. Bioorg Med Chem Lett. 2009 Dec 01; 19(23):6780-3.
-
Intraocular cryptococcoma. Arch Ophthalmol. 2009 May; 127(5):700-2.
-
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit. Gene Ther. 2006 Jan; 13(2):127-37.
-
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94.
-
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther. 2004 Nov; 10(5):916-28.
-
Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter. J Gastrointest Surg. 2004 Jan; 8(1):98-108; discussion 106-8.